1 Introduction
1.1 What is This Report About?
1.2 Definitions
1.3 Methodology
1.4 Profile of Survey Respondents: Global Pharmaceutical Industry
1.4.1 Profile of buyer respondents: global pharmaceutical industry
1.4.2 Profile of supplier respondents: global pharmaceutical industry
2 Executive Summary
3 Pharmaceutical Industry Supplier Marketing Spend Activity
3.1 Annual Marketing Budgets: Global Pharmaceutical Industry Suppliers
3.1.1 Annual marketing budgets by region: global pharmaceutical industry suppliers
3.1.2 Annual marketing budgets by company turnover: global pharmaceutical industry suppliers
3.2 Planned Change in Marketing Expenditure Levels: Global Pharmaceutical Industry Suppliers
3.2.1 Planned change in marketing expenditure by region: global pharmaceutical industry suppliers
3.2.2 Planned change in marketing expenditure by turnover: global pharmaceutical industry suppliers
3.2.3 Planned change in marketing expenditure levels vs. revenue growth expectations (%), 2012
3.3 Future Investment by Media Channel: Global Pharmaceutical Industry Suppliers
3.3.1 Future investment by media channel by region: global pharmaceutical industry suppliers
3.3.2 Future investment by media channel by company turnover: global pharmaceutical industry suppliers
3.4 Global Pharmaceutical Industry Suppliers’ Future Investment in Marketing and Sales
3.4.1 Investment in marketing and sales by region: global pharmaceutical industry suppliers
3.4.2 Investment in marketing and sales by region: global pharmaceutical industry suppliers
3.4.3 Investment in marketing and sales by turnover: global pharmaceutical industry suppliers
4 Marketing and Sales Behaviors and Strategies in 2012-2013
4.1 Key Marketing Aims for 2012-2013: Global Pharmaceutical Industry Suppliers
4.1.1 Key marketing aims by region: global pharmaceutical industry suppliers
4.1.2 Key marketing aims by company turnover: global pharmaceutical industry suppliers
4.1.3 Key marketing aims by revenue growth expectations: global pharmaceutical industry suppliers
4.2 Essential Amendments to Marketing Activities in 2012-2013
4.2.1 Amendments to marketing activities by region: global pharmaceutical industry suppliers
4.2.2 Amendments to marketing activities by company turnover: global pharmaceutical industry suppliers
4.3 Use of New Media for Business Prospects: Global Pharmaceutical Industry Suppliers
4.3.1 Use of new media by region: global pharmaceutical industry suppliers
4.3.2 Use of new media by company turnover: global pharmaceutical industry suppliers
4.4 Critical Success Factors for Choosing a Marketing Agency
4.4.1 Critical success factors for choosing a marketing agency by region
4.4.2 Critical success factors for choosing a marketing agency by company turnover: global pharmaceutical industry suppliers
5 Appendix
5.1 Global Pharmaceutical Industry Survey Results - Closed Questions
5.2 Methodology
5.3 Contact us
5.4 About ICD Research
5.5 Disclaimer
Table 1: Total Global Pharmaceutical Industry Survey Respondents by Company Type, 2012
Table 2: Global Pharmaceutical Industry Buyer Respondents by Job Role (%), 2012
Table 3: Global Pharmaceutical Industry Buyer Respondents by Company Turnover (%), 2012
Table 4: Global Pharmaceutical Industry Buyer Respondents by Region (%), 2012
Table 5: Global Pharmaceutical Industry Supplier Respondents by Job Role (%), 2012
Table 6: Global Pharmaceutical Industry Supplier Respondents by Company Turnover (%), 2012
Table 7: Global Pharmaceutical Industry Supplier Respondents by Region (%), 2012
Table 8: Annual Marketing Budgets: Global Pharmaceutical Industry Suppliers (%), 2010-2012
Table 9: Annual Marketing Budgets by Region: Global Pharmaceutical Industry Suppliers (%), 2012
Table 10: Annual Marketing Budgets by Turnover: Global Pharmaceutical Industry Suppliers (%), 2012
Table 11: Planned Change in Marketing Expenditure: Global Pharmaceutical Suppliers (%), 2010-2012
Table 12: Planned Change in Marketing Expenditure Levels by Region (%), 2012
Table 13: Planned Change in Marketing Expenditure Levels by Company Turnover (%), 2012
Table 14: Change in Marketing Expenditure Levels by Revenue Growth Expectations (%), 2012
Table 15: Net Change in Planned Marketing Expenditure, All Industries Comparison (%) 2012
Table 16: Future Investment by Media Channels : Global Pharmaceutical Industry Suppliers (%), 2012
Table 17: Investment in Marketing and Sales: Global Pharmaceutical Industry Suppliers (%) , 2012
Table 18: Investment in Marketing and Sales by Region: Global Pharmaceutical Industry Suppliers (%) , 2012
Table 19: Investment in Marketing and Sales by Turnover: Global Pharmaceutical Industry Suppliers (%) , 2012
Table 20: Key Marketing Aims: Global Pharmaceutical Industry Suppliers (%), 2012
Table 21: Amendments to Marketing Activities: Global Pharmaceutical Industry Suppliers (%) , 2012
Table 22: Amendments to Marketing by Region: Global Pharmaceutical Industry Suppliers (%) , 2012
Table 23: Amendments to Marketing by Turnover: Global Pharmaceutical Industry Suppliers (%) , 2012
Table 24: Use of New Media by Suppliers: Global Pharmaceutical Industry (%),2012
Table 25: Use of New Media by Region: Global Pharmaceutical Industry (%),2012
Table 26: Use of New Media by Company Turnover: Global Pharmaceutical Industry (%),2012
Table 27: Critical Success Factors: Global Pharmaceutical Industry Suppliers (%), 2010-2012
Table 28: Critical Success Factors by Region: Global Pharmaceutical Industry Suppliers (%), 2012
Table 29: Critical Success Factors by Turnover: Global Pharmaceutical Industry Suppliers (%), 2012
Table 30: Survey Results - Closed Questions
Figure 1: Annual Marketing Budgets: Global Pharmaceutical Industry Suppliers (%), 2010-2012
Figure 2: Annual Marketing Budgets by Region: Global Pharmaceutical Industry Suppliers (%), 2012
Figure 3: Annual Marketing Budgets by Turnover: Global Pharmaceutical Industry Suppliers (%), 2012
Figure 4: Planned Change in Marketing Expenditure: Global Pharmaceutical Suppliers (%), 2010-2012
Figure 5: Planned Change in Marketing Expenditure Levels by Region (%), 2012
Figure 6: Planned Change in Marketing Expenditure Levels by Company Turnover (%), 2012
Figure 7: Future Investment by Media Channels : Global Pharmaceutical Industry Suppliers (%), 2012
Figure 8: Global Pharmaceutical Industry Suppliers: Investment in Media Channels by Region (%), 2012
Figure 9: Global Pharmaceutical Industry Suppliers: Investment in Media Channels by Turnover (%), 2012
Figure 10: Investment in Marketing and Sales: Global Pharmaceutical Industry Suppliers (%), 2012
Figure 11: Investment in Marketing and Sales by Region: Global Pharmaceutical Industry Suppliers (%), 2012
Figure 12: Investment in Marketing and Sales by Turnover: Global Pharmaceutical Industry Suppliers (%), 2012
Figure 13: Key Marketing Aims: Global Pharmaceutical Industry Suppliers (%), 2012
Figure 14: Key Marketing Aims by Region: Global Pharmaceutical Industry Suppliers (%), 2012
Figure 15: Key Marketing Aims by Turnover: Global Pharmaceutical Industry Suppliers (%), 2012
Figure 16: Key Marketing Aims by Revenue Growth Expectations: Global Pharmaceutical Industry Suppliers (%), 2012
Figure 17: Amendments to Marketing Activities: Global Pharmaceutical Industry Suppliers (%) , 2012
Figure 18: Amendments to Marketing by Region: Global Pharmaceutical Industry Suppliers (%) , 2012
Figure 19: Amendments to Marketing by Turnover: Global Pharmaceutical Industry Suppliers (%) , 2012
Figure 20: Use of New Media by Suppliers: Global Pharmaceutical Industry (%), 2012
Figure 21: Use of New Media by Region: Global Pharmaceutical Industry (%), 2012
Figure 22: Use of New Media by Company Turnover: Global Pharmaceutical Industry (%), 2012
Figure 23: Critical Success Factors: Global Pharmaceutical Industry Suppliers (%), 2012
Figure 24: Critical Success Factors by Region: Global Pharmaceutical Industry Suppliers (%), 2012
Figure 25: Critical Success Factors by Turnover: Global Pharmaceutical Industry Suppliers (%), 2012